Drug profile · INN
isoetharine hydrochloride
ISOETHARINE HYDROCHLORIDE
isoetharine hydrochloride (ISOETHARINE HYDROCHLORIDE) is a beta-2 adrenergic receptor agonist. Associated with Aldeyra Therapeutics. Route of administration: inhalation. Current US regulatory status: approved.
Drug details — isoetharine hydrochloride
- US status
- approved
- Class
- —
- Route
- INHALATION
- Patents
- 20
- Programs
- 0
- Data quality
- 0.89
Quick answer
isoetharine hydrochloride (ISOETHARINE HYDROCHLORIDE) is a beta-2 adrenergic receptor agonist. Associated with Aldeyra Therapeutics. Route of administration: inhalation. Current US regulatory status: approved.
Key facts
Mechanism of action
Beta-2 adrenergic receptor agonist
Primary target: Beta-2 adrenergic receptor
Approval history
| Authority | Status | Date |
|---|---|---|
| FDA | approved | — |
Related & competitor drugs
Related patents
-
US 12240816
Deuterated compounds and uses thereof
granted -
US 12029735
Polymorphic compounds and uses thereof
granted -
US 12006298
Polymorphic compounds and uses thereof
granted -
US 11845722
Deuterated compounds and uses thereof
granted -
US 11724987
Compositions and methods of treating retinal disease
granted -
US 11590089
Beta-2 selective adrenergic receptor agonists
granted -
US 11459300
Deuterated compounds and uses thereof
granted -
US 11312692
Polymorphic compounds and uses thereof
granted -
US 11046650
Deuterated compounds and uses thereof
granted -
US 10913722
Compositions and methods of treating retinal disease
granted -
US 10550085
Deuterated compounds and uses thereof
granted -
US 10414732
Polymorphic compounds and uses thereof
granted -
US 10202348
Compositions and methods of treating retinal disease
granted -
US 9896419
Compositions and methods of treating retinal disease
granted -
US 9650342
Compositions and methods of treating retinal disease
granted -
US 9604997
Peri-carbinols
granted -
US 9364471
Compositions and methods of treating retinal disease
granted -
US 9265759
Compositions and methods of treating retinal disease
granted -
US 9266928
Deletion of the beta 20-21 loop in HIV GP120 exposes the CD4 binding site for improved antibody binding and antibody induction
granted -
US 8628782
Deletion of the beta 20-21 loop in HIV gp120 exposes the CD4 binding site for improved antibody binding and antibody induction
granted
Frequently asked questions
What is isoetharine hydrochloride?
isoetharine hydrochloride (ISOETHARINE HYDROCHLORIDE) is a beta-2 adrenergic receptor agonist. Associated with Aldeyra Therapeutics. Route of administration: inhalation. Current US regulatory status: approved.
What is the brand name for isoetharine hydrochloride?
ISOETHARINE HYDROCHLORIDE is a marketed brand name for isoetharine hydrochloride. Check FDA Drugs@FDA for the current US label holder and prescribing information.
What is the US approval status of isoetharine hydrochloride?
isoetharine hydrochloride has approved status in the United States according to our Drugs@FDA-derived records. Verify on the official FDA label before clinical or commercial decisions.